These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6961853)

  • 1. Antimanic, antidepressant, and antipanic effects of opiates: clinical, neuroanatomical, and biochemical evidence.
    Gold MS; Pottash AC; Sweeney D; Martin D; Extein I
    Ann N Y Acad Sci; 1982; 398():140-50. PubMed ID: 6961853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current perspectives in the pharmacopsychiatry of depression and mania.
    Emrich HM; Günther R; Dose M
    Neuropharmacology; 1983 Mar; 22(3 Spec No):385-8. PubMed ID: 6304556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and neuroendocrine effects of opioid receptor agonists in psychopathologic states.
    Judd LL; Risch SC; Segal DS; Janowsky DS; Huey LY
    Psychiatr Clin North Am; 1983 Sep; 6(3):393-402. PubMed ID: 6359090
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid opiate detoxification: clinical evidence of antidepressant and antipanic effects of opiates.
    Gold MS; Pottash AL; Sweeney DR; Kleber HD; Redmond DE
    Am J Psychiatry; 1979 Jul; 136(7):982-3. PubMed ID: 453367
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for an endorphin dysfunction in methadone addicts: lack of ACTH response to naloxone.
    Gold MS; Pottash AL; Extein I; Martin DA; Finn LB; Sweeney DR; Kleber HD
    Drug Alcohol Depend; 1981 Nov; 8(3):257-62. PubMed ID: 6276118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonidine: inpatient studies from 1978 to 1981.
    Gold MS; Pottash AL; Extein I
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):35-8. PubMed ID: 7085583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric indications for clonidine: the neuropharmacologic and clinical basis.
    Bond WS
    J Clin Psychopharmacol; 1986 Apr; 6(2):81-7. PubMed ID: 3517082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of naloxone in schizophrenic psychoses and manic syndromes.
    Verhoeven WM; van Praag HM; de Jong JT
    Neuropsychobiology; 1981; 7(3):159-68. PubMed ID: 7231653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rationale for opiate withdrawal symptomatology.
    Gold MS; Kleber HD
    Drug Alcohol Depend; 1979 Sep; 4(5):419-24. PubMed ID: 228923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological challenges to the endogenous opioid system in affective illness.
    Cohen MR; Pickar D
    J Clin Psychopharmacol; 1981 Jul; 1(4):223-31. PubMed ID: 7028803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dexamethasone suppression test in panic disorder and agoraphobia.
    Curtis GC; Cameron OG; Nesse RM
    Am J Psychiatry; 1982 Aug; 139(8):1043-6. PubMed ID: 7091428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of psychotropic drugs in the treatment of compulsive opiate abusers: the rationale for their use.
    Kleber HD
    Adv Alcohol Subst Abuse; 1985 Fall-1986 Winter; 5(1-2):103-19. PubMed ID: 2870623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous panic and depressive disorder: response to antidepressant treatments.
    Grunhaus L; Rabin D; Greden JF
    J Clin Psychiatry; 1986 Jan; 47(1):4-7. PubMed ID: 3941058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy.
    Baetz M; Bowen RC
    Can J Psychiatry; 1998 Feb; 43(1):73-7. PubMed ID: 9494751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of psychiatric disorders in the effectiveness of a long-term methadone maintenance treatment].
    Fernández Miranda J; González García-Portilla M; Sáiz Martínez P; Gutiérrez Cienfuegos E; Bobes García J
    Actas Esp Psiquiatr; 2001; 29(4):228-32. PubMed ID: 11470057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endorphins in the cerebrospinal fluid of psychiatric patients.
    Pickar D; Naber D; Post RM; van Kammen DP; Kaye W; Rubinow DR; Ballenger JC; Bunney WE
    Ann N Y Acad Sci; 1982; 398():399-412. PubMed ID: 6297360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endorphin-locus coeruleus connection mediates opiate action and withdrawal.
    Gold MS; Byck R; Sweeney DR; Kleber HD
    Biomedicine; 1979 Feb; 30(1):1-4. PubMed ID: 223678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for maintenance pharmacotherapy of opiate dependence.
    Kreek MJ
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():205-30. PubMed ID: 1346939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of anxiety disorder in patients with mood disorders.
    Coplan JD; Gorman JM
    J Clin Psychiatry; 1990 Oct; 51 Suppl():9-13; discussion 14-7. PubMed ID: 2211575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled study of verapamil for treatment of panic disorder.
    Klein E; Uhde TW
    Am J Psychiatry; 1988 Apr; 145(4):431-4. PubMed ID: 2450479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.